Effect of a price transparency intervention in the electronic health record on clinician ordering of inpatient laboratory tests: The PRICE randomized clinical trial

JAMA Internal Medicine

Volumn 177, Issue 7, 2017, Pages 939-945

  Sedrak, Mina S ^a   Myers, Jennifer S ^b,c   Small, Dylan S ^d   Nachamkin, Irving ^c   Ziemba, Justin B ^e   Murray, Dana ^c   Kurtzman, Gregory W ^c   Zhu, Jingsan ^c   Wang, Wenli ^c   Mincarelli, Deborah ^c   Danoski, Daniel ^c   Wells, Brian P ^c   Berns, Jeffrey S ^c   Brennan, Patrick J ^c   Hanson, C William ^c   Dine, C Jessica ^c   Patel, Mitesh S ^c,d,f  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; ELECTRONIC HEALTH RECORD; FEMALE; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE; LABORATORY TEST; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ACCESS TO INFORMATION; AGED; CLINICAL DECISION MAKING; CLINICAL PRACTICE; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH PERSONNEL ATTITUDE; HOSPITAL LABORATORY; LABORATORY TECHNIQUE; MEDICARE; MIDDLE AGED; PROCEDURES; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ACCESS TO INFORMATION; ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; CLINICAL DECISION-MAKING; CLINICAL LABORATORY TECHNIQUES; COST-BENEFIT ANALYSIS; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; INPATIENTS; LABORATORIES, HOSPITAL; MALE; MEDICARE; MIDDLE AGED; PRACTICE PATTERNS, PHYSICIANS'; UNITED STATES;

EID: 85024497187     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2017.1144     Document Type: Article

References (25)

1. Zhi M, Ding EL, Theisen-Toupal J, Whelan J, Arnaout R. The landscape of inappropriate laboratory testing: a 15-year meta-analysis. PLoS One. 2013;8(11):e78962.
2. May TA, ClancyM, Critchfield J, et al. Reducing unnecessary inpatient laboratory testing in a teaching hospital. Am J Clin Pathol. 2006;126(2): 200-206.
3. Stuebing EA, Miner TJ. Surgical vampires and rising health care expenditure: reducing the cost of daily phlebotomy. Arch Surg. 2011;146(5):524-527.
4. Salisbury AC, Reid KJ, Alexander KP, et al. Diagnostic blood loss from phlebotomy and hospital-acquired anemia during acutemyocardial infarction. Arch Intern Med. 2011;171(18):1646-1653.
5. Gandhi TK, Kachalia A, Thomas EJ, et al. Missed and delayed diagnoses in the ambulatory setting: a study of closed malpractice claims. Ann Intern Med. 2006;145(7):488-496.
6. Hsiao C-J, Hing E. Use and characteristics of electronic health record systems among office-based physician practices: United States, 2001-2013. NCHS Data Brief. 2014;(143):1-8.
7. Riggs KR, DeCamp M. Providing price displays for physicians: which price is right? JAMA. 2014;312 (16):1631-1632
8. Silvestri MT, Bongiovanni TR, Glover JG, Gross CP. Impact of price display on provider ordering: a systematic review. J HospMed. 2016;11(1):65-76.
9. Goetz C, Rotman SR, Hartoularos G, Bishop TF. The effect of charge display on cost of care and physician practice behaviors: a systematic review. J Gen Intern Med. 2015;30(6):835-842.
10. Horn DM, Koplan KE, Senese MD, Orav EJ, Sequist TD. The impact of cost displays on primary care physician laboratory test ordering. J Gen Intern Med. 2014;29(5):708-714.
11. Feldman LS, Shihab HM, Thiemann D, et al. Impact of providing fee data on laboratory test ordering: a controlled clinical trial. JAMA Intern Med. 2013;173(10):903-908.
12. Durand DJ, Feldman LS, Lewin JS, Brotman DJ. Provider cost transparency alone has no impact on inpatient imaging utilization. J AmColl Radiol. 2013; 10(2):108-113.
13. Chien AT, Lehmann LS, Hatfield LA, et al. A Randomized trial of displaying paid price information on imaging study and procedure ordering rates [published online December 2, 2016]. J Gen Intern Med. doi:10.1007/s11606-016-3917-6
14. Penn Data Store. Penn Data Analytics Center. http://www.med.upenn.edu/dac/penn-data-store-warehouse.html. Accessed December 14, 2016.
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
16. Rogers WH. Regression standard errors in clustered samples. Stata Tech Bull. 1993;13:19-23.
17. Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics. 2000;56(2):645-646.
18. Newman SC. Biostatistical Methods in Epidemiology. New York, NY: Wiley; 2001:136.
19. Agresti A. An Introduction to Categorical Data Analysis. New York, NY: Wiley; 2007:108-109.
20. Sinaiko AD, Rosenthal MB. Increased price transparency in health care: challenges and potential effects. N Engl J Med. 2011;364(10): 891-894.
21. Cutler D, Dafny L. Designing transparency systems for medical care prices. N Engl J Med. 2011; 364(10):894-895.
22. Patel MS, Volpp KG. Leveraging insights from behavioral economics to increase the value of health-care service provision. J Gen Intern Med. 2012;27(11):1544-1547.
23. Sedrak MS, Patel MS, Ziemba JB, et al. Residents' self-report on why they order perceived unnecessary inpatient laboratory tests. J HospMed. 2016;11(12):869-872.
24. Iturrate E, Jubelt L, Volpicelli F, Hochman K. Optimize your electronic medical record to increase value: reducing laboratory overutilization. Am J Med. 2016;129(2):215-220.
25. Volpp KG. Price transparency: not a panacea for high health care costs. JAMA. 2016;315(17): 1842-1843.